Switching to humans, ZFNs were quite effective in modifying interleukin-2 receptor subunit gamma (IL2RG), noting that patients with X-linked severe combined immunodeficiency (X-SCID) have a defective IL2RG gene [30]. This evidence concerns the gene IL2RG and T-B+ severe combined immunodeficiency due to gamma chain deficiency.